Topiramate Capsule
Product Images NDC 24979-210

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 24979-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure 1)

A Kaplan-Meier plot showing cumulative rates for time to first seizure over 500 days comparing Topamax 50 mg/day (solid line) with Topamax 400 mg/day (dashed line). The graph includes sample sizes for each group and a reported p-value (0.0002). The y-axis represents cumulative seizure rates, and the x-axis represents time in days.*

FDA Label Image

Figure2 (Figure 2)

This bar chart compares the change from baseline to double-blind phase in average monthly migraine period rate for placebo and Topamax doses (50 mg/day, 100 mg/day, 200 mg/day) across two studies (Study 11 and Study 12). The vertical axis shows change in migraine rate, with Topamax doses demonstrating greater reductions than placebo, especially at 100 mg/day and 200 mg/day doses, with significant p-values indicated.*

FDA Label Image

Label 15mg (Label 15)

Label for Topiramate Capsules, USP 15 mg by Upsher-Smith Laboratories, LLC. The label shows the product name, strength 15 mg, quantity 60 capsules, Rx only status, and storage instructions. Manufacturer information is included, along with a barcode and a non-varnish area for serial tracking details.*

FDA Label Image

Label 25mg (Label 25)

Label for Topiramate Capsules, USP 25 mg by Upsher-Smith Laboratories, LLC. The label shows 60 capsules in the package with Rx only status. It includes storage instructions, capsule description, and manufacturing details from TWi Pharmaceuticals USA, Inc. and TWi Pharmaceuticals, Inc. Taiwan. The NDC is 24979-211-04.*

FDA Label Image

Logo (Logo 2)

FDA Label Image

Structure (Structure)

Chemical structure of the active ingredient Topiramate, showing its molecular configuration with labeled oxygen, sulfur, nitrogen, carbon, and hydrogen atoms forming the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.